- Chart
- Upturn Summary
- Fund Details
Upturn AI Summary
Robo Global® Healthcare Technology and Innovation ETF(HTEC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for HTEC
10/28/2026: HTEC (2-star) has a low Upturn Star Rating. Not recommended to BUY.
HTEC provides targeted exposure to the intersection of healthcare and technology by tracking a proprietary index of global innovators. It offers a thematic approach that captures potential growth in robotics, digital health, and precision medicine, which are not fully represented in broad-market healthcare ETFs. While it provides unique exposure, investors must weigh its higher expense ratio and lower liquidity against the long-term potential of its specialized holdings. The primary risks include sector concentration, interest rate sensitivity, and inherent volatility. It is most suitable for growth-oriented investors willing to maintain a long-term time horizon for their portfolio.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The focus on disruptive healthcare technology aligns well with long-term growth objectives. |
| Momentum investor | Strong fit while signal remains positive | Investors can capitalize on positive sector momentum during periods of high innovation and adoption. |
| Value investor | Weak fit | The high valuations inherent in innovative healthcare companies often conflict with traditional value-based metrics. |
| Dividend/Income investor | Weak fit | The fund prioritizes capital appreciation over dividend income, as most holdings reinvest earnings. |
| Low-risk investor | Weak fit | The sector's inherent volatility and concentration make it unsuitable for risk-averse portfolios. |
Investor Profile
Ideal Investor Profile
The ideal investor is one seeking long-term capital appreciation and has a high tolerance for volatility, specifically wishing to gain thematic exposure to healthcare innovation.
Suitability
HTEC is best suited for long-term growth-oriented investors who can tolerate thematic sector risks, rather than active traders or passive broad-market index followers.
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Volatility | High | Thematic investments in innovation often experience sharp price swings. |
| Market risk | Medium / high | General market downturns disproportionately affect high-multiple growth stocks. |
| Concentration | High | The focus on a narrow sector increases exposure to industry-specific regulatory or technological failures. |
| Tracking/expense | Medium | Higher expense ratios compared to broad ETFs can drag on long-term performance. |
| Liquidity | Medium | Lower average daily volume can lead to wider spreads and difficult entry or exit for larger positions. |
| Business/sector quality | Medium | The success of the fund depends on the clinical and commercial viability of the underlying companies' technologies. |
Risk Analysis
Volatility
HTEC exhibits high volatility due to its concentrated exposure to innovative and often smaller-cap healthcare technology firms.
Market Risk
The fund is highly sensitive to changes in sector-specific regulation and the broader performance of growth-oriented technology stocks.
What the ETF Owns
| Exposure Type | Exposure | Weight (%) | Retail Investor Read |
|---|---|---|---|
| Healthcare Equipment & Supplies | Medical Device and Robotics Manufacturers | 45 | These companies provide the foundational hardware and robotic tools used in modern precision surgery and patient care. |
| Health Care Technology | Digital Health and Diagnostic Systems | 35 | This sector includes companies developing software, AI, and digital platforms that improve diagnostic accuracy and patient monitoring. |
| Biotechnology / Life Sciences | Precision Medicine and Genetic Innovation | 15 | Exposure to companies using advanced technology to develop personalized treatments and genomic solutions. |
| Cash/collateral | Cash and Cash Equivalents | 5 | Reflects minimal residual cash held for operational purposes or pending reinvestment. |
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type ETF | Historic Profit 54.97% | Avg. Invested days 72 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | ETF Returns Performance |

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

